{"count":4,"index":{"built_at":"2026-07-26T22:54:44.174374+00:00","public_records":55311,"revision":"1f30a6d3704e85300347e1b1"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre"},"results":[{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":42.63566387,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specific risk markers. Therefore, the evidence for a direct connection between these particular DNA tests and menopause is unclear. A comprehensive risk assessment should include clinical parameters (blood pressure, lipids, fasting glucose) and lifestyle factors alongside genetic data. Interpretation requires medical guidance, especially during perimenopause.","area":"gesundheit","canonical_id":"gesundheit:canonical-dba57ce588eaf0504e5daffc","id":"public-1cba76d2e734dc592063d703","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","score":42.12570503,"snippet":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specif","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1cba76d2e734dc592063d703/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-wechseljahre-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. The evidence grade is 'unclear' or 'marketing' due to lack of valid sources.","area":"gesundheit","canonical_id":"gesundheit:canonical-eca159e96dde8dc626ae916d","id":"public-4fa927815a0c2d3bdf0b09f0","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","score":42.07174474,"snippet":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. T","sources":[],"title":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4fa927815a0c2d3bdf0b09f0/what-role-does-cardio-risk-check-herz-kreislauf-risiko-test-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, such a test might be used as a supplementary tool, but it should not replace standard medical risk assessment. Caveat: Do not make health decisions based solely on a consumer test; consult a physician for interpretation and follow-up.","area":"gesundheit","canonical_id":"gesundheit:canonical-45110f7524e07c3fb34a7c83","id":"public-e8826844de6a23448ca20ca4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","score":41.89699504,"snippet":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, suc","sources":[],"title":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e8826844de6a23448ca20ca4/is-cardio-risk-check-herz-kreislauf-risiko-test-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}